Table 2.
Demographic characteristics of the studied cohort.
| Character | Group | SARS-CoV-2 Infected | p Value | Controls |
p Value OR (95% CI) |
|---|---|---|---|---|---|
| N = 200 | N = 100 | ||||
| Gender (N) |
Female | Asymptomatic/Mild (26) Moderate (33) Severe/Fatal (30) |
>0.05 (a) | 13 |
0 (b) 5.36 (2.812–10.238) |
| Male | Asymptomatic/Mild (43) Moderate (34) Severe/Fatal (34) |
87 | |||
| Age (Mean ± SD) |
Asymptomatic/Mild | 69 (33.64 ± 13.25): *, ** | 0 (†) | ¯ | ¯ |
| Moderate | 67 (37.43 ± 11.75): *, *** | ||||
| Severe/Fatal | 64 (50.59 ± 15.7): **, *** |
N: N number of subjects, SD: Standard Deviation, CI: Confidence Interval; * Post hoc Bonferroni (p = 0.321) between Asymptomatic/Mild and Moderate patients; ** Post hoc Bonferroni (p = 0) between Asymptomatic/Mild and Severe/Fatal patients; *** Post hoc Bonferroni (p = 0) between Moderate and Severe/Fatal patients; †: One-way ANOVA test; (a) Chi-squared test between clinical groups and (b) Infected–control individuals; 95% CI: 95% confidence interval.